BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26524393)

  • 1. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
    Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
    J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.
    Han J; Gao X; Liu R; Yang J; Zhang M; Mi Y; Shi Y; Gao Q
    Chem Biol Drug Des; 2016 Jun; 87(6):867-77. PubMed ID: 26706102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates.
    Liu R; Fu Z; Zhao M; Gao X; Li H; Mi Q; Liu P; Yang J; Yao Z; Gao Q
    Oncotarget; 2017 Jun; 8(24):39476-39496. PubMed ID: 28467806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
    Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
    Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
    Li T; Gao X; Yang L; Shi Y; Gao Q
    ChemMedChem; 2016 May; 11(10):1069-77. PubMed ID: 27135196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
    Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
    Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo.
    Patra M; Awuah SG; Lippard SJ
    J Am Chem Soc; 2016 Sep; 138(38):12541-51. PubMed ID: 27570149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1.
    Liu R; Li H; Gao X; Mi Q; Zhao H; Gao Q
    Biochem Biophys Res Commun; 2017 May; 487(1):34-40. PubMed ID: 28385528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
    Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
    Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticulate platinum(II) anticancer drug: synthesis and characterization of amphiphilic cyclotriphosphazene-platinum(II) conjugates.
    Yu JY; Jun YJ; Jang SH; Lee HJ; Sohn YS
    J Inorg Biochem; 2007 Nov; 101(11-12):1931-6. PubMed ID: 17709142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
    Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
    Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Activity Assessment and DNA Binding Properties of Two Binuclear Platinum (II) Complexes using Spectroscopic and Molecular Simulation Approaches.
    Alavianmehr MM; Ashrafi A; Yousefi R; Haghighi MG; Abolmaali SS; Moosavi-Movahedi AA; Rad MNS
    Anticancer Agents Med Chem; 2020; 20(17):2066-2073. PubMed ID: 32628598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
    Margiotta N; Savino S; Gandin V; Marzano C; Natile G
    ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and cytotoxicity of dihalogeno-platinum(II) complexes with L-histidine ligand.
    Ye QS; Xie MJ; Liu WP; Chen XZ; Yu Y; Chang QW; Hou SQ
    Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):424-7. PubMed ID: 19336943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target.
    Almahmoud S; Wang X; Vennerstrom JL; Zhong HA
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents.
    Cincinelli R; Musso L; Dallavalle S; Artali R; Tinelli S; Colangelo D; Zunino F; De Cesare M; Beretta GL; Zaffaroni N
    Eur J Med Chem; 2013 May; 63():387-400. PubMed ID: 23517728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.